NEW YORK, Feb. 9, 2011 /PRNewswire/ -- Questcor
Pharmaceuticals Inc. (Nasdaq: QCOR) will replace Sonic Solutions
(Nasdaq: SNIC) in the S&P SmallCap 600 index after the close of
trading on a date to be announced. Sonic Solutions is being
acquired by S&P MidCap 400 constituent Rovi Corp. (Nasdaq:
ROVI) in a deal expected to be completed soon.
Standard & Poor's will monitor this transaction, and post
any relevant updates on its website: www.standardandpoors.com.
Questcor provides prescription drugs for central nervous system
and inflammatory disorders. Headquartered in Union City, CA, the company will be added to
the S&P SmallCap 600 GICS (Global Industry Classification
Standard) Pharmaceuticals Sub-Industry index.
Following is a summary of the change:
|
S&P
SMALLCAP 600 INDEX – TBA
|
|
|
COMPANY
|
GICS
ECONOMIC SECTOR
|
GICS
SUB-INDUSTRY
|
|
|
ADDED
|
Questcor
Pharmaceuticals
|
Health
Care
|
Pharmaceuticals
|
|
|
DELETED
|
Sonic
Solutions
|
Information
Technology
|
Application
Software
|
|
|
|
|
|
For more information about S&P Indices, please visit
www.standardandpoors.com/indices.
About S&P Indices
S&P Indices, the world's leading index provider, maintains a
wide variety of investable and benchmark indices to meet an array
of investor needs. Over $1.25
trillion is directly indexed to Standard & Poor's family
of indices, which includes the S&P 500, the world's most
followed stock market index, the S&P/Case-Shiller Home Price
Indices, the leading measure of U.S. home prices, the S&P
Global BMI, an index with approximately 11,000 constituents, the
S&P GSCI, the industry's most closely watched commodities
index, and the S&P National AMT-Free Municipal Bond Index, the
premier investable index for U.S. municipal bonds. For more
information, please visit www.standardandpoors.com/indices.
|
For more information
contact:
|
|
|
|
|
David M. Blitzer,
Ph.D.
|
|
|
Managing Director & Chairman
of the Index Committee
|
|
|
(212) 438-3907
|
|
|
SOURCE Standard & Poor's